Abstract
A copper-catalyzed coupling of aryl, heteroaryl, and vinyl iodides with α-silyldifluoroamides is reported. The reaction forms α,α-difluoro-α-aryl amides from electron-rich, electron-poor, and sterically hindered aryl iodides in high yield and tolerates a variety of functional groups. The aryldifluoroamide products can be further transformed to provide access to a diverse array of difluoroalkylarenes, including compounds of potential biological interest.
Keywords: enolate arylation, difluoroamide, cross-coupling, fluorine, copper
Graphical Abstract
Fluorinated compounds are common in pharmaceuticals, agrochemicals, and materials, due to their favorable biological and physical properties.[1] In medicinal chemistry, fluorinated substituents can alter the lipophilicity, metabolic stability, and overall activity of biologically active compounds, relative to their non-fluorinated counterparts.[2] The difluoromethylene (CF2) group has particular value because it is considered a bioisostere of carbonyl groups and ethers[3] and can modulate the pKa of neighboring functional groups, such as amines.[4]
Aryldifluoroamides are present in several biologically active compounds, including the inhibitor of FKBP12[3] and the modulator of AMPAR[5] shown in Figure 1. Moreover, amides can be transformed into amines, alcohols, acids, esters, and ketones, making aryldifluoroamides versatile precursors to a variety of difluoroalkylarenes. Despite the biological and synthetic potential of this class of compound, current methods for the synthesis of difluoroamides are limited. Aryldifluoroamides can by prepared by deoxyfluorination of dicarbonyl compounds with diethylaminosulfur trifluoride (DAST) or related aminosulfur trifluorides.[6] However, these fluorinating reagents release toxic HF upon contact with water and can undergo explosive decomposition upon heating.
Figure 1.
Bioactive compounds containing aryldifluoroamide groups.
The cross coupling of aryl halides with difluorinated enolates would be a valuable approach to the synthesis of aryldifluorocarboxylic acid derivatives. Cross-coupling reactions of aryl nucleophiles, such as arylboronic acids, with difluorocarboxylic acid derivatives as electrophiles have been reported,[7] but reactions of the more widely accessible aryl halides with a carbonyl derivative as the nucleophile would be a more direct method from chemical feedstocks. A synthesis of aryldifluoroamides by the reductive coupling of aryl iodides and iododifluoroamides has been reported,[8] but the reaction requires excess copper (6 equiv) and displays limited scope and functional group tolerance. For example, the reaction occurs in low yields with electron-rich or sterically hindered aryl iodides, and coupling reactions of heteroaryl iodides have not been reported. Our group recently reported a palladium-catalyzed coupling of aryl bromides with silyldifluoroamides.[9] This reaction occurs with broad scope, but this reaction did not occur with many medicinally relevant heterocycles, such as 2-halopyridines. In addition, this reaction required palladium as the central metal of the catalyst, and we sought to develop a catalytic coupling reaction based on a cost-effective and earth-abundant first-row metal. Amii and coworkers reported a coupling of α-silyldifluoroesters with aryl iodides in the presence of stoichiometric CuI. The reaction also proceeded with catalytic CuI, but yields were variable (40–71%), and the reaction was limited to electron-deficient substrates.[10] A related coupling of halopyridines was also reported, but required two equivalents of CuI.[11]
Herein, we report the cross coupling of aryl halides with α-silyldifluoroamides in the presence of a catalytic quantity of CuOAc. The reactions encompass aryl and heteroaryl iodides containing a range of functional groups and steric and electronic properties and occur with a commercially available copper catalyst without the need for any added ligand. Furthermore, we demonstrate that the aryldifluoroamide products are synthetically useful precursors to difluorinated analogs of biologically active compounds.
The arylation of α-silyldifluoroamide 2 with 1-butyl-4-iodobenzene was chosen as a model system to identify a copper catalyst and reaction conditions for the cross-coupling reaction. Compound 2 was synthesized from the corresponding chlorodifluoroamide, in analogy to a procedure for the synthesis of α-silyldifluoroesters reported by Amii.[10] Compound 2 is an air-stable solid that can be prepared on multi-gram scale. By employing a pre-formed silyl amide enolate, we sought to avoid the requirement for a strong base required to generate a difluoroamide enolate in situ via deprotonation of a difluoroamide. We envisioned that the silyldifluoroamide could be activated by a fluoride source under mild conditions.
Various copper(I) sources were found to effect the coupling of 2 and 1-butyl-4-iodobenzene. Reactions catalyzed by CuOAc proceeded in higher yields than those catalyzed by CuI, CuBr•SMe2, CuCl, or CuCN (Table 1). None of the copper(II) sources tested catalyzed the coupling process (see Table S1 in the Supporting Information). Reactions conducted with CuOAc without added ligand proceeded in higher yields than those conducted with added ligand (see Table S2 in the Supporting Information). The reaction catalyzed by CuOAc (20 mol %) in toluene in the presence of KF and 18-crown-6 formed the coupled product in 87% yield, as measured by 19F NMR spectroscopy, and in 82% isolated yield. The reaction of 1a and 2 conducted in DMSO in the absence of 18-cr-6 (entry 5) proceeded in yields that are comparable to those from the conditions described in entry 6. However, the conditions described in entry 6 were applicable to a wider range of substrates, and afforded the coupling products of electron-rich aryl iodides in higher yield than the conditions described in entry 5.
Table 1.
Effect of Reaction Conditions on the Coupling of 1-Butyl-4-iodobenzene with α-Silyldifluoroamide 2[a]
![]() | ||||
---|---|---|---|---|
Entry | solvent | temperature | CuX | yield [%][b] |
1 | DMSO | 80 °C | CuCl | <5 |
2 | DMSO | 80 °C | CuBr•SMe2 | 14 |
3 | DMSO | 80 °C | CuI | 18 |
4 | DMSO | 80 °C | CuCN | 12 |
5 | DMSO | 80 °C | CuOAc | 89 |
6[c] | toluene | 100 °C | CuOAc | 87 |
General conditions: 0.100 mmol 1a, 0.120 mmol 2, and 0.0200 mmol CuX1 in 0.25 mL of solvent.
Yields were determined by 19F NMR spectroscopy.
1.2 equiv 18-cr-6 and 2.0 equiv 2.
Having identified conditions for the coupling of 2 with 1-butyl-4-iodobenzene, we investigated the conversion of a variety of aryl iodides to the corresponding aryldifluoroamides (Scheme 1). Electron-rich, electron-neutral, and electron-poor aryl iodides coupled with 2 in high yield. In contrast to many copper-catalyzed coupling reactions, which occur in significantly lower yields with sterically hindered aryl iodides,[12] the reactions of 2 with aryl iodides containing mono- or di-substitution adjacent to the iodine atom (1c–1e, 1i, 1n) occurred in high yield. The reaction conditions were found to tolerate ester (1g), nitrile (1f), tertiary amine (1o), ether (1h–1l), and aromatic bromide (1e) groups. Although free hydroxyl groups, primary or secondary amines, and enolizable ketones were found to be incompatible with the reaction conditions, aryl iodides containing protected alcohol (1j) and ketone (1k) groups coupled in high yields.
Scheme 1.
Isolated yield. General conditions: aryl iodide (0.400 mmol), 2 (0.800 mmol), CuOAc (0.0800 mmol), KF (0.480 mmol), 18-crown-6 (0.480 mmol), toluene (1 mL), 100 °C, 24 h.
Heteroarenes are ubiquitous in pharmaceuticals, agrochemicals, and materials,[13] but the metal-catalyzed coupling of basic heteroarenes can be challenging to effect because they can coordinate to and potentially deactivate transition metal catalysts. However, electron-poor heteroaryl iodides, such 2-iodo pyridine, quinoline, and pyrazine, coupled with silyl difluoroamide 2 in the presence of catalytic CuOAc to afford the corresponding heteroaryldifluoroamides (3p–3r) in high yield.
Recent studies in our group demonstrated that heteroaryl bromides react with (phen)CuRF complexes to form perfluoroalkylarenes in high yield,[14] and studies by other groups have shown that ligandless perfluoroalkyl copper compounds generated in situ also react with heteroaryl halides.[15] Therefore, we investigated the copper-catalyzed reactions of α-silyldifluoroamides with heteroaryl bromides to form α,α-difluoro-α-aryl amides.
Coupling of halopyridines and -quinolines at the electron-poor 2- and 4- positions is challenging with palladium catalysts, often requiring high catalyst loadings and occurring in low yields and with limited scope. For example, 2-bromopyridine and 2-bromoquinoline did not undergo coupling with α-silyldifluoroamides under the palladium-catalyzed conditions previously reported by our group.[9] To investigate the reactivity of these substrates in the presence of a copper catalyst, the coupling of 2-bromopyridine with α-silyldifluoroamide 2 was chosen as a model reaction. The conditions identified for the coupling of 2 with iodoarenes (vide supra) resulted in only 21% yield of the product from coupling of 2 with 2-bromopyridine. However, the same reaction conducted with KF as an additive in NMP as solvent in place of toluene resulted in 79% yield of the product from coupling of the bromopyridine. Other nitrogen-containing heteroaryl bromides, such as 2- and 4-bromoquinoline, coupled with 2 in moderate yield (Scheme 2).
Scheme 2.
Reactions were performed on a 0.100 mmol scale to determine yields by 19F NMR spectroscopy. Yields of isolated products are shown in parentheses for reactions performed on a 0.400 mmol scale. General conditions: aryl bromide (1 equiv), 2 (1.5 equiv), CuOAc (20 mol %), KF (1.2 equiv), 100 °C, 24 h. aReactions performed with toluene as solvent and 18-cr-6 (1.2 equiv) as additive.
Vinyl iodides also coupled with 2 in high yield (Scheme 3). The coupling reactions of both trans and cis vinyl iodides afforded the corresponding vinyldifluoroamides (6a and 6b, respectively) as single stereoisomers with retention of the alkene geometry.
Scheme 3.
Isolated yield. General conditions: vinyl iodide (0.400 mmol), 2 (0.800 mmol), CuOAc (0.0800 mmol), KF (0.480 mmol), 18-crown-6 (0.480 mmol), toluene (1 mL), 100 °C, 24 h.
A variety of α-silyldifluoroamides coupled with aryl iodides under the reaction conditions (Scheme 4). Tertiary amides containing both cyclic and acyclic groups on nitrogen coupled with 1-butyl-4-iodobenzene in high yield. Varying degrees of steric bulk at the amide nitrogen atom were tolerated; dialkyl amides ranging from dimethyl- to diisopropylamides underwent coupling with 1-butyl-4-iodobenzene in 73 to 92% yield.
Scheme 4.
Isolated yield. General conditions: 1 (0.400 mmol), α-silyldifluoroamide (0.800 mmol), KF (0.480 mmol), CuOAc (0.0800 mmol), 18-crown-6 (0.480 mmol), toluene (1 mL), 100 °C, 24 h.
Aryldifluoroacetamides can serve as precursors to a variety of difluoroalkylarenes.[9] Because of the unique access to 2-pyridyldifluoroamides by this coupling chemistry, we investigated the transformation of a 2-pyridyl amide into a range of 2-difluoroalkylpyridines. This pyridyl amide underwent transformations under conditions related to those we reported to occur with electron neutral aryldifluoroamides (Scheme 5).[9] The morpholinoamide 3p was reduced to amine 9a with BH3•THF in 71% yield, and to alcohol 9b with excess sodium borohydride in 76% yield. Pyridyldifluoroamide 3p also underwent addition of a single equivalent of an alkyl Grignard reagent in 72% yield to afford a product (9e) equivalent to the unknown coupling of an aryl halide at the difluoromethyl group of the enolate of an alkyl difluoromethyl ketone. Monoaddition of alkyl- and arylmetal reagents is not limited to morpholinoamides: diethyl and piperidinyl amides were also converted to ketones in high yield (see Scheme S1 in the Supporting Information).
Scheme 5.
Isolated yield for a reaction of 0.500 mmol 3p unless otherwise stated. [a] BH3•THF, THF, reflux. [b] NaBH4, EtOH, reflux. [c] TMSCl, EtOH, reflux. [d] NaOH, EtOH, r.t. Yield was determined by 19F NMR spectroscopy. [e] Pentylmagnesium bromide, THF, −78 °C. [f] Reaction of 0.300 mmol 8f. n-Butyllithium, THF, −78 °C. [g] Reaction of 0.300 mmol 8a. Phenyllithium, THF, −78 °C.
As noted in the introduction, the fluorine atoms in the α-position to the amide carbonyl group render the carbon more electrophilic than that in a typical amide. Consistent with this hypothesis, hydrolysis or alcoholysis of difluoroamide 3p to the corresponding carboxylic acid or ester occurred under mild conditions in 76 and 79% yield, respectively. The conditions for this hydrolysis were milder than those for hydrolysis of non-fluorinated amides, suggesting that selective hydrolysis of an aryldifluoramide group in the presence of non-fluorinated amides is feasible.
Copper-catalyzed enolate arylation reactions of aryl halides have been proposed in some cases to proceed via the intermediacy of aryl radicals,[16] and in other cases to proceed through a copper(I)/(III) cycle without the intermediacy of aryl radicals.[17] To investigate the potential that the coupling reactions of difluoroamide enolates occur through aryl radicals, we conducted the coupling reaction with 1-(allyloxy)-2-iodobenzene (Scheme 6). The corresponding aryl radical has been reported to undergo cyclization with a rate constant of 9.6*109 s−1.[18] The absence of 3-methyl-2,3-dihydrobenzofuran, which would be formed after hydrogen-atom abstraction from the solvent by the product of cyclization of the aryl radical, would provide evidence against the intermediacy of aryl radicals. The reaction of 1-(allyloxy)-2-iodobenzene under the standard CuOAc-catalyzed coupling conditions did not form cyclized products, implying that this reaction occurs, like other copper-catalyzed coupling reactions, without the intermediacy of an aryl radical. In addition, the coupling of (Z)-iodooctene proceeds with complete retention of the olefin geometry. If the reaction occurred through a vinyl radical, a mixture of (E) and (Z) stereoisomers of the coupled products would be expected to form.
Scheme 6.
Probe for the intermediacy of aryl radicals.
Due to the versatility of both the copper-catalyzed coupling reaction and the transformations of the coupled products, we sought to apply our methodology to the synthesis of difluoro derivatives of biologically active compounds. Substituting fluorine atoms for hydrogen atoms at positions prone to oxidation has become a common strategy for increasing the metabolic stability of medicinal compounds.[2a] Because benzylic positions are common sites of metabolic oxidation, we targeted analogs of biologically active compounds containing two fluorine atoms at a benzylic position.
By the coupling chemistry in this work, we synthesized a difluorinated analog of pioglitazone, a drug for the treatment of type 2 diabetes (Scheme 7). The reaction of a 2-bromopyridine with compound 2 formed 10b, which was reduced to the corresponding alcohol. The alcohol was converted to the corresponding tosylate, but the aryldifluoroalkyl tosylate was less reactive toward substitution than the unfluorinated analog, and substitution with phenol derivative 10d did not occur. However, alkyl triflate 10c underwent Williamson etherification with phenol derivative 10d to afford difluoro-pioglitazone (10e) in 88% yield.
Scheme 7.
Synthesis of difluoro-pioglitazone. [a] nBuLi, Me2N(CH2)2OH, CBr4, hexane, 0 °C → r.t. [b] CuOAc (20 mol %), KF (1.2 equiv), 2 (2 equiv), NMP, 100 °C. [c] NaBH4, EtOH, reflux. [d] Tf2O, pyr, CH2Cl2, r.t. [e] NaH, 10d, DMF, 50 °C.
The copper-catalyzed reaction of an electron-rich aryl iodide with an α-silyldifluoroamide was exploited for the synthesis of a difluoro analog of the cardiac drug verapamil (Scheme 8). 3,4-Dimethoxyiodobenzene coupled with 2 in the presence of CuOAc in 93% yield. Compound 11a was then converted to the corresponding acid in 87% yield and coupled with amine 11c. The resulting amide was reduced to the amine to afford difluoro-verapamil (11d) in 75% yield over the last two steps and in 61% yield over the four-step sequence.
Scheme 8.
Synthesis of difluoro-verapamil. [a] CuOAc (20 mol %), KF (1.2 equiv), 18-cr-6 (1.2 equiv), 2 (2 equiv), toluene, 100 °C. [b] NaOH, EtOH, 65 °C. [c] CDI, DMAP, 11c, CH2Cl2, r.t. [d] Zn(OAc)2, HSiMe(OEt)2, THF, 65 °C.
Finally, we synthesized a difluorinated analog of ropinirole, a drug for the treatment of Parkinson’s disease (Scheme 9). Protected indole 12b participated in the copper-catalyzed coupling, which enabled the synthesis of indole 12c. Compound 12c was then reduced to amine 12d in 89% yield. Finally, oxidation of the indole to the corresponding oxindole (12e), followed by deprotection, afforded difluoro-ropinirole (12f).
Scheme 9.
Synthesis of difluoro-ropinirole. [a] CuI, DMEDA, NaI, dioxane, 110 °C. [b] NaH, PMBCl, DMF, 0 °C → r.t. [c] CuOAc (20 mol %), KF (1.2 equiv), 18-cr-6 (1.2 equiv), TMSCF2CONPr2 (2 equiv), toluene, 100 °C. [d] Zn(OAc)2, HSiMe(OEt)2, THF, 65 °C. [e] NCS, toluene/HCl, 100 °C. [f] PhOMe, H2SO4, TFA, 100 °C.
In summary, we have developed a procedure for the synthesis of aryldifluoroamides from aryl halides and α-silyldifluoroamides. The reaction is catalyzed by commercially available CuOAc, does not require the addition of an exogenous ligand, and is applicable to the coupling of electron-rich, electron-poor, and sterically hindered aryl and heteroaryl iodides with a variety of α-silyldifluoroamides. We demonstrated that the aryldifluoroamide products can be converted to a range of difluoroalkylarenes that would otherwise be difficult to access, and that aryldifluoroamides serve as versatile intermediates for the synthesis of compounds of biological interest. Work is ongoing to develop general conditions for the copper-catalyzed coupling of difluoroenolates with aryl bromides and to develop more general methods for the coupling of fluorinated nucleophiles.
Supplementary Material
Footnotes
The authors thank NIH (GM058108) for support of this work. S. I. A. acknowledges the NSF for a graduate fellowship. We thank Dr. Patrick S. Fier for the synthesis of (Z)-iodooctene.
Supporting information for this article is given via a link at the end of the document.
References
- 1.a) Kirk KL. Org Process Res Dev. 2008;12:305–321. [Google Scholar]; b) Jeschke P. ChemBioChem. 2004;5:570–589. doi: 10.1002/cbic.200300833. [DOI] [PubMed] [Google Scholar]; c) Dolbier WR., Jr J Fluorine Chem. 2005;126:157–163. [Google Scholar]; d) Yamazaki T, Taguchi T, Ojima I. Fluorine in Medicinal Chemistry and Chemical Biology. John Wiley & Sons, Ltd; 2009. pp. 1–46. [Google Scholar]; e) Kirsch P. Modern Fluoroorganic Chemistry. Wiley-VCH Verlag GmbH & Co. KGaA; 2013. pp. 1–24. [Google Scholar]
- 2.a) Purser S, Moore PR, Swallow S, Gouverneur V. Chem Soc Rev. 2008;37:320–330. doi: 10.1039/b610213c. [DOI] [PubMed] [Google Scholar]; b) Müller K, Faeh C, Diederich F. Science. 2007;317:1881–1886. doi: 10.1126/science.1131943. [DOI] [PubMed] [Google Scholar]; c) Hagmann WK. J Med Chem. 2008;51:4359–4369. doi: 10.1021/jm800219f. [DOI] [PubMed] [Google Scholar]; d) Smart BE. J Fluorine Chem. 2001;109:3–11. [Google Scholar]
- 3.Dubowchik GM, Vrudhula VM, Dasgupta B, Ditta J, Chen T, Sheriff S, Sipman K, Witmer M, Tredup J, Vyas DM, Verdoorn TA, Bollini S, Vinitsky A. Org Lett. 2001;3:3987–3990. doi: 10.1021/ol0166909. [DOI] [PubMed] [Google Scholar]
- 4.a) Grunewald GL, Seim MR, Lu J, Makboul M, Criscione KR. J Med Chem. 2006;49:2939–2952. doi: 10.1021/jm051262k. [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Smyth MS, Ford H, Jr, Burke TR., Jr Tetrahedron Lett. 1992;33:4137–4140. [Google Scholar]; c) O’Hagan D, Wang Y, Skibinski M, Slawin AMZ. Pure Appl Chem. 2012;84 [Google Scholar]
- 5.Ward SE, Harries M, Aldegheri L, Austin NE, Ballantine S, Ballini E, Bradley DM, Bax BD, Clarke BP, Harris AJ, Harrison SA, Melarange RA, Mookherjee C, Mosley J, Dal Negro G, Oliosi B, Smith KJ, Thewlis KM, Woollard PM, Yusaf SP. J Med Chem. 2010;54:78–94. doi: 10.1021/jm100679e. [DOI] [PubMed] [Google Scholar]
- 6.a) Lal GS, Pez GP, Pesaresi RJ, Prozonic FM, Cheng H. J Org Chem. 1999;64:7048–7054. [Google Scholar]; b) Middleton WJ, Bingham EM. J Org Chem. 1980;45:2883–2887. [Google Scholar]; c) Singh RP, Majumder U, Shreeve JM. J Org Chem. 2001;66:6263–6267. doi: 10.1021/jo0157674. [DOI] [PubMed] [Google Scholar]
- 7.a) Feng Z, Min QQ, Xiao YL, Zhang B, Zhang X. Angew Chem, Int Ed. 2014;53:1669–1673. doi: 10.1002/anie.201309535. [DOI] [PubMed] [Google Scholar]; Angew Chem. 2014;6:1695–1699. [Google Scholar]; b) Xiao YL, Guo WH, He GZ, Pan Q, Zhang X. Angew Chem, Int Ed. 2014;53:9909–9913. doi: 10.1002/anie.201405653. [DOI] [PubMed] [Google Scholar]; Angew Chem. 2014;126:10067–10071. [Google Scholar]
- 8.Zhu J, Zhang W, Zhang L, Liu J, Zheng J, Hu J. J Org Chem. 2010;75:5505–5512. doi: 10.1021/jo1005262. [DOI] [PubMed] [Google Scholar]
- 9.Ge S, Arlow SI, Mormino MG, Hartwig JF. J Am Chem Soc. 2014;136:14401–14404. doi: 10.1021/ja508590k. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Fujikawa K, Fujioka Y, Kobayashi A, Amii H. Org Lett. 2011;13:5560–5563. doi: 10.1021/ol202289z. [DOI] [PubMed] [Google Scholar]
- 11.Fujikawa K, Kobayashi A, Amii H. Synthesis. 2012;44:3015–3018. [Google Scholar]
- 12.Hartwig JF. Organotransition Metal Chemistry: From Bonding to Catalysis. University Science Books; Sausalito, California: 2010. [Google Scholar]
- 13.Eicher THS, Speicher A. The Chemistry of Heterocycles: Structures, Reactions, Synthesis, and Applications. Wiley-VCH; 2012. [Google Scholar]
- 14.Mormino MG, Fier PS, Hartwig JF. Org Lett. 2014;16:1744–1747. doi: 10.1021/ol500422t. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.a) Zanardi A, Novikov MA, Martin E, Benet-Buchholz J, Grushin VV. J Am Chem Soc. 2011;133:20901–20913. doi: 10.1021/ja2081026. [DOI] [PubMed] [Google Scholar]; b) Serizawa H, Aikawa K, Mikami K. Chem Eur J. 2013;19:17692–17697. doi: 10.1002/chem.201303828. [DOI] [PubMed] [Google Scholar]; c) Lishchynskyi A, Novikov MA, Martin E, Escudero-Adán EC, Novák P, Grushin VV. J Org Chem. 2013;78:11126–11146. doi: 10.1021/jo401423h. [DOI] [PubMed] [Google Scholar]; d) Lishchynskyi A, Grushin VV. J Am Chem Soc. 2013;135:12584–12587. doi: 10.1021/ja407017j. [DOI] [PubMed] [Google Scholar]
- 16.a) Setsune J, Ueda T, Shikata K, Matsukawa K, Iida T, Kitao T. Tetrahedron. 1986;42:2647–2656. [Google Scholar]; b) Setsune J, Matsukawa K, Kitao T. Tetrahedron Lett. 1982;23:663–666. [Google Scholar]
- 17.Huang Z, Hartwig JF. Angew Chem, Int Ed. 2012;51:1028–1032;. doi: 10.1002/anie.201106719. [DOI] [PMC free article] [PubMed] [Google Scholar]; Angew Chem. 2012;124:1052–1056. [Google Scholar]
- 18.Annunziata A, Galli C, Marinelli M, Pau T. Eur J Org Chem. 2001;2001:1323–1329. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.